Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

16.57 -0.02 (-0.12%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
24 25 Next >
2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE
While the tenor was more bearish, the late-day rally found the market close to where it finished 2022. 
Via Talk Markets
Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
2 "Safe" Stocks That Are Anything But
Sometimes, business models that sound safe still fail to deliver for shareholders. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
4 Analysts Have This to Say About Teva Pharmaceutical Indus
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
Via Benzinga
Why Teva Stock Sank On Thursday
There were two major developments with the company, both of which involved piles of money. 
Via The Motley Fool
Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
From Alvotech
Via GlobeNewswire
My Top 5 Portfolio Holdings for 2023
This mix of growth and value stocks can outperform in a challenging environment. 
Via The Motley Fool
Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity
Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
Is Prometheus Biosciences a Good Stock to Buy Right Now?
This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead. 
Via The Motley Fool
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
These three leading companies are ripe for the picking and may never be this cheap again. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
Via Benzinga
Stocks Move Higher As Wall Street Eyes China Lockdowns
The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well. 
Via Talk Markets
Teva Finalizes Nationwide Opioid Settlement Terms
From Teva Pharmaceutical Industries Limited
Via Business Wire
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
Via InvestorPlace
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. 
Via InvestorPlace
Teva Announces Appointment of Richard Francis as President and CEO
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
From Teva Pharmaceutical Industries Limited
Via Business Wire
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at... 
Via Benzinga
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three... 
Via Benzinga
Adding $100 to These 5 Stocks Would Be a Genius Move Right Now
You don't need a large pile of cash to begin building wealth on Wall Street. 
Via The Motley Fool
Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Why Teva Stock Stumbled Again on Friday
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments. 
Via The Motley Fool
Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript
TEVA earnings call for the period ending September 30, 2022. 
Via The Motley Fool
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.